- (HealthDay News) — Here are the latest clinical trials, courtesy
of CenterWatch:

Lower Back Pain

If you are aged 18 to 65, have moderate-to-severe low
back pain, and the current episode has lasted two days or less, you may
qualify for this study.

The research site is in Denver, Colo.

More information

Please see http://www.centerwatch.com/patient/studies/cat700.html.<
/p>

—–

Neuroblastoma

This phase IIa trial is studying the side effects and
best dose of Ultratrace iodine I 131 MIBG, followed by a stem cell
transplant in treating young people with relapsed or refractory high-risk
neuroblastoma.

The research site is in Madison, Wisc.

More information

Please see http://www.centerwatch.com/patient/studies/cat342.html.<
/p>

—–

Diabetic Neuropathy

If you have type 1 or type 2 diabetes mellitus and a
history of chronic pain attributable to a symmetrical stocking
distribution neuropathy in the lower extremities, you may qualify for this
study.

The research site is in Murrells Inlet, S.C.

More information

Please see http://www.centerwatch.com/patient/studies/cat253.html.<
/p>

—–

Copyright 2008 CenterWatch. All rights reserved.